Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Therapeutic Drug Monitoring|January 1, 1986
Pharmacokinetics of rifampin in children. I. Multiple dose intravenous infusionJ R Koup, J Williams-Warren, A Weber, et al.
Developmental Pharmacology and Therapeutics|January 1, 1980
Factors affecting theophylline pharmacokinetics in premature infants with apneaD M Hilligoss, W J Jusko, J R Koup, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1979
Relationship between serum and saliva chloramphenicol concentrationsJ R Koup, A H Lau, B Brodsky, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1975
Digoxin concentrations in serum and salivaW J Jusko, L Gerbracht, L H Golden, et al.
Clinical Pharmacokinetics|September 25, 1999
Clinical pharmacokinetics of troglitazoneC M Loi, M Young, E Randinitis, et al.
Clinical Pharmacology and Therapeutics|July 1, 1975
Digoxin pharmacokinetics: role of renal failure in dosage regimen designJ R Koup, W J Jusko, C M Elwood, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1981
Comparison of enzymatic and liquid chromatographic chloramphenicol assaysA F Weber, K E Opheim, J R Koup, et al.
Therapeutic Drug Monitoring|March 1, 1991
Sensitivity analysis of the effect of bioavailability or dosage form content on mean steady state phenytoin concentrationT M Ludden, S R Allerheiligen, T R Browne, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1987
Effect of orally administered activated charcoal on vancomycin clearanceR L Davis, R A Roon, J R Koup, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Comparison of single and multiple dose pharmacokinetics of theophylline using stable isotopesR E Vestal, K E Thummel, G D Mercer, et al.
Pageof 9